Submitted by Anonymous (not verified) on 23 February 2026 - 16:12
Human medicines European public assessment report (EPAR): Ogivri, trastuzumab, Date of authorisation: 12/12/2018, Revision: 13, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Ogivri, trastuzumab, Date of authorisation: 12/12/2018, Revision: 13, Status: Authorised